Article
Gut microbiome alterations in preclinical Alzheimer’s disease
29 Nov 2022
Abstract excerpt
BACKGROUND: Although some human studies have reported gut microbiome changes in individuals with Alzheimer's disease (AD) dementia or mild cognitive impairment (MCI), gut microbiome alterations in preclinical AD, i.e., cerebral amyloidosis without cognitive impairment, is largely unknown. OBJECTIVE: We aimed to identify gut microbial alterations associated with preclinical AD by comparing cognitively normal (CN)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
